SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001144204-19-038914
Filing Date
2019-08-09
Accepted
2019-08-09 16:31:35
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tv527250_424b5.htm 424B5 5371
2 GRAPHIC image_001.jpg GRAPHIC 4974
  Complete submission text file 0001144204-19-038914.txt   13461
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-222046 | Film No.: 191013349
SIC: 2836 Biological Products, (No Diagnostic Substances)